Papers

7

Total Citations

285

H-Index

5

About

Dr. Shulin Zhao is a pioneering pancreatic surgeon whose work has fundamentally reshaped the landscape of minimally invasive pancreatic surgery, particularly through the adoption and refinement of the robotic surgical platform. Based at a high-volume pancreatic center in China, Dr. Zhao’s primary research focuses on the learning curve, safety, and oncologic efficacy of robot-assisted pancreaticoduodenectomy (RPD) and middle pancreatectomy. His landmark study on short-term outcomes after RPD, which has garnered over 120 citations, provided critical evidence that, once the learning curve is overcome, robotic surgery offers outcomes comparable to open surgery. Dr. Zhao’s comprehensive analysis of a 450-case learning curve (115 citations) is a seminal guide for surgeons worldwide, systematically defining the phases of skill acquisition and process optimization. His work extends to complex procedures like robot-assisted middle pancreatectomy, where he has reported on one of the largest single-center series. By demonstrating the feasibility and safety of these advanced techniques, Dr. Zhao is not only advancing surgical practice but also training the next generation of robotic pancreatic surgeons, making a lasting impact on the field.

Research Focus

Key Achievements

5
H-Index
7
Papers
285
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Short-term Outcomes After Robot-Assisted vs Open Pancreaticoduodenectomy After the Learning Curve
121 citations · 2020
📈 Most Prolific Year: 2019 (4 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Ruijin Hospital, Shanghai Jiao Tong University, Army Medical University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago